Skip to Content
Morningstar

VanEck Biotech ETF BBH

Morningstar Medalist Rating
Medalist Rating as of | See VanEck Investment Hub

Morningstar’s Analysis BBH

Will BBH outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable BBH’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the BBH management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of BBH’s parent organization’s priorities and whether they’re in line with investors’ interests.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit VanEck Biotech ETF to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBH

More BBH Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 68.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Amgen Inc

14.95 61.7 Mil
Healthcare

Vertex Pharmaceuticals Inc

9.61 39.7 Mil
Healthcare

Gilead Sciences Inc

8.01 33.0 Mil
Healthcare

Regeneron Pharmaceuticals Inc

7.87 32.5 Mil
Healthcare

Moderna Inc

5.66 23.3 Mil
Healthcare

IQVIA Holdings Inc

4.82 19.9 Mil
Healthcare

argenx SE ADR

4.47 18.4 Mil
Healthcare

Biogen Inc

4.26 17.6 Mil
Healthcare

Icon PLC

4.20 17.3 Mil
Healthcare

Illumina Inc

4.18 17.2 Mil
Healthcare